Related Experiment Video
Updated: Mar 19, 2026
Robot-assisted Partial Splenectomy
Published on: January 2, 2026
Total versus partial splenectomy in pediatric hereditary spherocytosis: A systematic review and meta-analysis
1Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.
Insights
Total splenectomy (TS) is more effective than partial splenectomy (PS) for improving hemoglobin and reducing reticulocytes in pediatric hereditary spherocytosis. Long-term outcomes and complications require further investigation with patient registries.
Area of Science:
- Pediatric Hematology
- Surgical Oncology
- Clinical Effectiveness Research
Background:
- Hereditary spherocytosis (HS) is a hemolytic anemia requiring management.
- Splenectomy is a common treatment, but the optimal surgical approach (total vs. partial) remains debated.
- Understanding the comparative effectiveness of TS and PS is crucial for pediatric HS management.
Purpose of the Study:
- To systematically review and meta-analyze the clinical effectiveness of total splenectomy (TS) versus partial splenectomy (PS) in pediatric hereditary spherocytosis.
- To compare hematologic parameters and secondary outcomes between TS and PS.
- To inform surgical decision-making for pediatric HS patients.
Main Methods:
- Systematic review and meta-analysis of 14 observational studies.
- Comparison of pre- and postoperative hematologic parameters (hemoglobin, reticulocytes).
- Analysis of secondary outcomes including infections, complications, recurrence, and biliary disease.
Main Results:
- Total splenectomy (TS) demonstrated greater efficacy in increasing hemoglobin (3.6 g/dl vs. 2.2 g/dl) and reducing reticulocytes (12.5% vs. 6.5%) compared to partial splenectomy (PS) at 1 year.
- Outcomes following PS remained stable for at least 6 years.
- No cases of overwhelming postsplenectomy sepsis were reported in the included studies.
Conclusions:
- Total splenectomy (TS) appears more effective than partial splenectomy (PS) for short-term hematologic improvement in pediatric hereditary spherocytosis.
- Long-term stability of PS outcomes is noted, but further data is needed.
- A population-based patient registry is recommended for comprehensive long-term follow-up and safety evaluation.
Abstract:
To compare the clinical effectiveness of total splenectomy (TS) or partial splenectomy (PS) in pediatric hereditary spherocytosis, a systematic review and meta-analysis was performed (PROSPERO registration CRD42015030056). There were 14 observational studies comparing pre- and postoperative hematologic parameters. Secondary outcomes include in-hospital infections, surgical complications, symptomatic recurrence, and biliary disease. TS is more effective than PS to increase hemoglobin (3.6 g/dl vs. 2.2 g/dl) and reduce reticulocytes (12.5% vs. 6.5%) after 1 year; outcomes following PS are stable for at least 6 years. There were no cases of overwhelming postsplenectomy sepsis. A population-based patient registry is needed for long-term follow-up.
